Omega Therapeutics Inc. (OMGA)
0.60
0.00 (0.50%)
At close: Jan 15, 2025, 12:58 PM
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to free cash flow ratio, price per earnings, and much more.
| Year | FY23 | FY22 | FY21 | FY20 | FY19 |
| Net Income | -97.43M | -102.70M | -68.28M | -29.45M | -17.95M |
| Depreciation & Amortization | 6.77M | 5.19M | 1.39M | 1.15M | 794.00K |
| Stock-Based Compensation | 8.79M | 7.75M | 3.18M | 637.00K | 335.00K |
| Other Working Capital | -2.37M | -10.51M | 3.88M | 1.43M | 510.00K |
| Other Non-Cash Items | -280.00K | 1.13M | 106.00K | -59.00K | -41.00K |
| Deferred Income Tax | n/a | n/a | 1.33M | 25.00K | -3.00K |
| Change in Working Capital | -9.37M | -9.88M | 4.66M | 1.56M | 1.18M |
| Operating Cash Flow | -91.51M | -98.52M | -57.61M | -26.13M | -15.68M |
| Capital Expenditures | -2.87M | -1.38M | -1.47M | -1.81M | -885.00K |
| Acquisitions | n/a | 16.68M | n/a | n/a | n/a |
| Purchase of Investments | -19.77M | -57.41M | -38.93M | n/a | n/a |
| Sales Maturities Of Investments | 69.50M | 40.73M | n/a | n/a | n/a |
| Other Investing Acitivies | 650.00K | -16.68M | -38.93M | n/a | n/a |
| Investing Cash Flow | 47.52M | -18.06M | -40.40M | -1.81M | -885.00K |
| Debt Repayment | 1.62M | n/a | 8.00M | n/a | 4.00M |
| Common Stock Repurchased | n/a | n/a | n/a | n/a | n/a |
| Dividend Paid | n/a | n/a | n/a | n/a | n/a |
| Other Financial Acitivies | 200.00K | 708.00K | 122.30M | 48.62M | 7.99M |
| Financial Cash Flow | 41.82M | 708.00K | 261.54M | 48.62M | 11.98M |
| Net Cash Flow | -2.17M | -115.87M | 163.53M | 20.68M | -4.58M |
| Free Cash Flow | -94.38M | -99.89M | -59.08M | -27.94M | -16.56M |